Drugs / Lactobacillus Rhamnosus Lcr35®
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02789605 | Jan 2018 → Nov 2019 | aphthous stomatitis | Centre Hospitalier Universitaire de Nice | Completed | No outcome recorded |
| Phase 2 | NCT02730741 | Jun 2016 | non-infectious diarrheal disease | Biose | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus Rhamnosus Lcr35 | “a probiotic, the Lactobacillus rhamnosus Lcr35®” NCT02789605 ↗1“Lactobacillus Rhamnosus Lcr35®” NCT02730741 ↗ |
| Known as | Lcr restituo sachet | “Drug: Lcr restituo® sachet” NCT02730741 ↗ |
| Modality | Other / unclassified | “Total freeze-dried culture” NCT02730741 ↗ |
| Route | Oral | “Oral Treatment” NCT02730741 ↗ |